<DOC>
	<DOC>NCT01073059</DOC>
	<brief_summary>- This trial is conducted to assess pharmacokinetic characteristics of valproic acid when valproic acid single treatment and valproic acid &amp; ertapenem combination treatment - This trial is performed to evaluate safety of the combination treatment compare with single treatment - The investigators carry this trial out to study mechanism of combination treatment</brief_summary>
	<brief_title>Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Subjects</brief_title>
	<detailed_description />
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Subjects who are healthy volunteers, men 19~50 years Subjects who have a weight more then 50kg and a condition ± 20% range of ideal weight Subjects with evidence of clinically significant hepatic, pancreatic, renal, neurological, pulmonary, endocrine, blood tumor, psychiatric or cardiovascular disease Subjects who have a GI disease (crohn's disease, etc.) that would increase the influence with absorbance medication or a GI surgery excluding appendectomy and hernia surgery Subjects with uncontrolled hypotension (indicated by a sitting systolic blood pressure≤ 100 mmHg or diastolic blood pressure≤ 65 mmHg measured) and hypertension (indicated by a sitting systolic blood pressure≥ 150 mmHg or diastolic blood pressure≥ 95 mmHg measured) at vital sign measurement Subjects with known allergy, hypersensitivity (anaphylaxistype reaction; especially penicillin antibiotics) Subjects with a history of drug abuse Subjects who received certain medication (include oriental medicine) within the past 3 weeks or certain OTCdrug within 1 week Subjects who participated in other clinical investigation within 2months prior to first administration Subjects who did whole blood donation (within 2months) or apheresis (within 1months) prior to first administration Subjects who are chronic drinkers</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>valproic acid</keyword>
	<keyword>ertapenem</keyword>
</DOC>